You've wandered off the track again. I wasn't comparing Lonza Singapore to anything. I was pointing out that the FDA often seem to complete their investigations or evaluation of evidence before making a determination of approval or issuing a CRL, and that they seldom stop the process until it is complete. They don't stop at the first apparent defect or fault because the evaluation of the fault and the nature of remediation is done at a later stage.
2023 The Final Countdown, page-2018
-
- There are more pages in this discussion • 1,386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |